,coef,coef_graph,coef_combined,coef_combined_zscore,coef_combined2
Diseases associated with the TLR signaling cascade,1.8559956e-06,12.0,1.8559956e-06,-0.16002569,-1.5499353
SLBP independent Processing of Histone Pre-mRNAs,3.368873e-06,2.0,3.368873e-06,-0.15919413,0.11981157
Diseases associated with glycosylation precursor biosynthesis,0.0,16.0,0.0,-0.16104583,-2.2183213
Signaling by NOTCH4,2.2632919e-07,4.0,2.2632919e-07,-0.16092142,-0.21524413
GPVI-mediated activation cascade,1.76053e-05,2.0,1.76053e-05,-0.1513691,0.12535733
Ion transport by P-type ATPases,8.420922e-08,2.0,8.420922e-08,-0.16099955,0.118532024
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",1.3365315e-05,2.0,1.3365315e-05,-0.1536996,0.12370567
Signaling by SCF-KIT,0.00048732918,2.0,0.00048732918,0.106813855,0.3083374
Small interfering RNA (siRNA) biogenesis,2.0946952e-06,2.0,2.0946952e-06,-0.1598945,0.119315214
Diseases associated with glycosaminoglycan metabolism,1.0978292e-08,16.0,1.0978292e-08,-0.1610398,-2.218317
Diseases associated with visual transduction,2.747343e-07,3.0,2.747343e-07,-0.16089483,-0.048309505
Mitochondrial protein import,1.8120913e-06,2.0,1.8120913e-06,-0.16004983,0.119205125
Transport of Mature Transcript to Cytoplasm,4.64104e-05,3.0,4.64104e-05,-0.13553643,-0.030337455
Dissolution of Fibrin Clot,7.4199896e-08,2.0,7.4199896e-08,-0.16100506,0.11852813
Abacavir metabolism,2.0532569e-05,2.0,2.0532569e-05,-0.14976014,0.12649766
RNA polymerase II transcribes snRNA genes,8.6963766e-05,2.0,8.6963766e-05,-0.113246344,0.1523758
Influenza Infection,1.7692076e-07,3.0,1.7692076e-07,-0.16094859,-0.04834762
Regulation of Apoptosis,8.1762363e-07,3.0,8.1762363e-07,-0.16059643,-0.048098035
Laminin interactions,1.7460517e-05,2.0,1.7460517e-05,-0.15144868,0.12530094
Kinesins,2.6685464e-07,2.0,2.6685464e-07,-0.16089916,0.118603185
rRNA processing in the mitochondrion,1.3688685e-07,2.0,1.3688685e-07,-0.1609706,0.11855254
Plasma lipoprotein clearance,3.2678116e-05,6.0,3.2678116e-05,-0.14308435,-0.53643405
HDACs deacetylate histones,0.00042575444,2.0,0.00042575444,0.0729694,0.28435108
Signaling by PTK6,6.0620637e-06,10.0,6.0620637e-06,-0.15771383,-1.2144653
Lipid particle organization,9.839005e-09,2.0,9.839005e-09,-0.16104043,0.11850306
Gap junction trafficking and regulation,6.38342e-06,3.0,6.38342e-06,-0.15753719,-0.045929883
Glycogen metabolism,1.641973e-06,3.0,1.641973e-06,-0.16014332,-0.0477769
C-type lectin receptors (CLRs),7.1334507e-06,4.0,7.1334507e-06,-0.15712494,-0.2125535
Inhibition of TSC complex formation by PKB,1.7909993e-08,2.0,1.7909993e-08,-0.161036,0.1185062
Wax biosynthesis,9.818581e-08,2.0,9.818581e-08,-0.16099186,0.118537486
RET signaling,0.00010769225,2.0,0.00010769225,-0.10185296,0.16045055
Glucagon signaling in metabolic regulation,1.0291154e-06,2.0,1.0291154e-06,-0.16048019,0.11890012
G2/M Checkpoints,3.960854e-06,4.0,3.960854e-06,-0.15886876,-0.21378937
Surfactant metabolism,2.6124988e-07,2.0,2.6124988e-07,-0.16090225,0.11860099
DNA strand elongation,1.7682543e-06,4.0,1.7682543e-06,-0.1600739,-0.21464348
mRNA 3'-end processing,4.0388873e-05,2.0,4.0388873e-05,-0.13884616,0.13423264
Asparagine N-linked glycosylation,0.000111101646,4.0,0.000111101646,-0.09997899,-0.17205286
"Incretin synthesis, secretion, and inactivation",9.560541e-05,3.0,9.560541e-05,-0.10849647,-0.011173619
RHO GTPase Effectors,9.1578906e-05,12.0,9.1578906e-05,-0.110709645,-1.514984
Butyrophilin (BTN) family interactions,1.7723823e-06,2.0,1.7723823e-06,-0.16007164,0.11918966
Rab regulation of trafficking,0.00038911327,3.0,0.00038911327,0.05282964,0.10316183
RNA Polymerase I Chain Elongation,2.2468191e-06,2.0,2.2468191e-06,-0.15981087,0.11937447
Protein methylation,4.2909676e-07,2.0,4.2909676e-07,-0.16080998,0.11866639
Glucose metabolism,3.310181e-05,3.0,3.310181e-05,-0.14285147,-0.035521787
Transport of inorganic cations/anions and amino acids/oligopeptides,9.801194e-05,11.0,9.801194e-05,-0.10717373,-1.3455622
"Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism",5.297467e-05,6.0,5.297467e-05,-0.13192838,-0.5285276
Miscellaneous transport and binding events,8.183249e-06,2.0,8.183249e-06,-0.15654793,0.121686995
Choline catabolism,2.3152753e-09,2.0,2.3152753e-09,-0.16104455,0.11850013
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,5.7667656e-08,2.0,5.7667656e-08,-0.16101414,0.11852168
"Transport of vitamins, nucleosides, and related molecules",2.8112386e-06,5.0,2.8112386e-06,-0.15950064,-0.38115293
"ROS, RNS production in phagocytes",1.070838e-05,2.0,1.070838e-05,-0.15516,0.12267066
IRE1alpha activates chaperones,5.2045757e-06,2.0,5.2045757e-06,-0.15818514,0.120526664
Formation of xylulose-5-phosphate,3.0192e-06,2.0,3.0192e-06,-0.15938634,0.11967536
Macroautophagy,6.1937254e-07,2.0,6.1937254e-07,-0.1607054,0.11874049
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,4.5826627e-11,2.0,4.5826627e-11,-0.1610458,0.11849926
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),1.0266213e-05,2.0,1.0266213e-05,-0.15540303,0.1224984
Platelet Adhesion to exposed collagen,7.1839544e-08,2.0,7.1839544e-08,-0.16100636,0.11852721
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),2.5272186e-07,2.0,2.5272186e-07,-0.16090694,0.11859767
Inwardly rectifying K+ channels,1.6034117e-05,5.0,1.6034117e-05,-0.1522327,-0.376002
IPs transport between cytosol and ER lumen,0.0,2.0,0.0,-0.16104583,0.11849923
Positive epigenetic regulation of rRNA expression,0.015581986,3.0,0.015581986,8.403567,6.0215178
KSRP (KHSRP) binds and destabilizes mRNA,2.6248497e-07,2.0,2.6248497e-07,-0.16090156,0.118601486
Eukaryotic Translation Initiation,2.7025775e-05,3.0,2.7025775e-05,-0.14619115,-0.03788869
Rap1 signalling,4.291148e-05,2.0,4.291148e-05,-0.1374596,0.13521531
RNA Polymerase II Transcription Termination,9.011177e-05,2.0,9.011177e-05,-0.11151604,0.15360211
SRP-dependent cotranslational protein targeting to membrane,0.00012558322,2.0,0.00012558322,-0.09201922,0.16741994
Metabolism of polyamines,8.052392e-05,7.0,8.052392e-05,-0.11678599,-0.68471164
Signaling by Hippo,3.122883e-08,2.0,3.122883e-08,-0.16102867,0.118511386
Intrinsic Pathway of Fibrin Clot Formation,1.8032266e-05,2.0,1.8032266e-05,-0.15113443,0.12552367
Energy dependent regulation of mTOR by LKB1-AMPK,1.495215e-05,2.0,1.495215e-05,-0.15282741,0.124323815
Phenylketonuria,0.0,2.0,0.0,-0.16104583,0.11849923
CREB3 factors activate genes,4.513503e-05,2.0,4.513503e-05,-0.13623744,0.1360815
ESR-mediated signaling,5.487822e-06,2.0,5.487822e-06,-0.15802947,0.120637
Switching of origins to a post-replicative state,5.374908e-07,3.0,5.374908e-07,-0.1607504,-0.04820716
NCAM signaling for neurite out-growth,2.3592173e-10,2.0,2.3592173e-10,-0.1610457,0.11849932
Protein ubiquitination,0.0021128012,3.0,0.0021128012,1.0002519,0.77462125
Clathrin-mediated endocytosis,0.00028554778,2.0,0.00028554778,-0.0040949597,0.22973382
RNA Polymerase III Transcription Initiation,9.909615e-06,4.0,9.909615e-06,-0.15559903,-0.21147203
GP1b-IX-V activation signalling,1.1440961e-05,2.0,1.1440961e-05,-0.15475734,0.12295603
MGMT-mediated DNA damage reversal,6.6925146e-08,2.0,6.6925146e-08,-0.16100904,0.11852531
Protein repair,6.9303487e-06,2.0,6.9303487e-06,-0.15723658,0.12119893
IPs transport between ER lumen and nucleus,0.0,2.0,0.0,-0.16104583,0.11849923
Neurotransmitter clearance,5.3020553e-06,3.0,5.3020553e-06,-0.15813157,-0.04635113
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1.6980141e-06,2.0,1.6980141e-06,-0.16011253,0.11916069
Transcription-Coupled Nucleotide Excision Repair (TC-NER),0.0013401661,4.0,0.0013401661,0.5755743,0.30672693
Lysosomal oligosaccharide catabolism,3.7233779e-06,2.0,3.7233779e-06,-0.1589993,0.11994966
Fatty acid metabolism,1.7741446e-05,7.0,1.7741446e-05,-0.15129429,-0.7091684
Tandem pore domain potassium channels,8.093704e-08,7.0,8.093704e-08,-0.16100135,-0.716048
Glycosaminoglycan metabolism,0.0023348,6.0,0.0023348,1.1222733,0.3603533
Listeria monocytogenes entry into host cells,3.6918376e-08,3.0,3.6918376e-08,-0.16102554,-0.04840214
Plasma lipoprotein assembly,2.2252095e-06,4.0,2.2252095e-06,-0.15982275,-0.21446547
HSP90 chaperone cycle for steroid hormone receptors (SHR),2.7661988e-08,2.0,2.7661988e-08,-0.16103064,0.11850999
EPH-Ephrin signaling,1.7035538e-05,5.0,1.7035538e-05,-0.15168227,-0.37561184
Latent infection of Homo sapiens with Mycobacterium tuberculosis,0.0,2.0,0.0,-0.16104583,0.11849923
Nucleotide salvage,4.3268983e-06,3.0,4.3268983e-06,-0.15866756,-0.04673099
Activation of Matrix Metalloproteinases,4.4758107e-08,2.0,4.4758107e-08,-0.16102123,0.11851667
IPs transport between ER lumen and cytosol,0.0,2.0,0.0,-0.16104583,0.11849923
Mitotic G1-G1/S phases,6.202067e-05,4.0,6.202067e-05,-0.12695627,-0.19117226
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",2.6205331e-09,2.0,2.6205331e-09,-0.16104439,0.11850025
Advanced glycosylation endproduct receptor signaling,1.1016762e-06,2.0,1.1016762e-06,-0.16044031,0.11892838
tRNA processing in the nucleus,3.8898515e-06,2.0,3.8898515e-06,-0.15890779,0.1200145
Signaling by the B Cell Receptor (BCR),0.0030700893,4.0,0.0030700893,1.5264237,0.9806153
Amine-derived hormones,5.0138497e-06,4.0,5.0138497e-06,-0.15828997,-0.21337916
Phase I - Functionalization of compounds,0.00027335747,7.0,0.00027335747,-0.0107953455,-0.60959363
RNA Polymerase II Transcription Elongation,1.2413e-06,3.0,1.2413e-06,-0.16036355,-0.04793298
Triglyceride metabolism,5.291783e-06,3.0,5.291783e-06,-0.15813722,-0.046355136
Cytosolic iron-sulfur cluster assembly,4.8776574e-06,2.0,4.8776574e-06,-0.15836483,0.12039931
Signaling by TGF-beta Receptor Complex,7.2594157e-06,4.0,7.2594157e-06,-0.1570557,-0.21250442
HuR (ELAVL1) binds and stabilizes mRNA,2.4614346e-07,2.0,2.4614346e-07,-0.16091055,0.11859511
Cellular response to heat stress,9.161341e-05,4.0,9.161341e-05,-0.11069067,-0.17964447
Plasma lipoprotein remodeling,0.00020037078,5.0,0.00020037078,-0.05091236,-0.304194
Hh mutants abrogate ligand secretion,2.4316918e-07,3.0,2.4316918e-07,-0.16091219,-0.048321806
IP6 and IP7 transport between cytosol and nucleus,0.0,2.0,0.0,-0.16104583,0.11849923
Mitotic G2-G2/M phases,2.6595246e-05,3.0,2.6595246e-05,-0.1464278,-0.038056396
Plasmalogen biosynthesis,7.2543386e-08,2.0,7.2543386e-08,-0.16100596,0.118527494
Mitochondrial ABC transporters,2.5028183e-05,2.0,2.5028183e-05,-0.14728913,0.12824892
Heme degradation,7.607263e-07,2.0,7.607263e-07,-0.16062771,0.11879556
Platelet calcium homeostasis,2.0193802e-08,3.0,2.0193802e-08,-0.16103473,-0.04840867
Common Pathway of Fibrin Clot Formation,6.9703006e-08,2.0,6.9703006e-08,-0.16100752,0.118526384
Striated Muscle Contraction,0.00014911086,2.0,0.00014911086,-0.079087295,0.17658508
"Base-Excision Repair, AP Site Formation",2.0114724e-06,3.0,2.0114724e-06,-0.15994023,-0.04763296
Intra-Golgi and retrograde Golgi-to-ER traffic,9.264502e-05,4.0,9.264502e-05,-0.11012364,-0.17924261
Cargo trafficking to the periciliary membrane,5.4213262e-05,5.0,5.4213262e-05,-0.13124761,-0.36112937
Mitochondrial translation,8.704314e-05,4.0,8.704314e-05,-0.11320271,-0.1814248
Interaction With Cumulus Cells,0.0,2.0,0.0,-0.16104583,0.11849923
Molecules associated with elastic fibres,7.0891365e-05,2.0,7.0891365e-05,-0.122080505,0.14611483
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,1.9224686e-05,6.0,1.9224686e-05,-0.15047902,-0.54167485
Digestion of dietary carbohydrate,1.6221793e-06,2.0,1.6221793e-06,-0.1601542,0.11913115
Processing of SMDT1,6.839642e-06,2.0,6.839642e-06,-0.15728644,0.12116359
Signaling by MET,3.3864033e-06,9.0,3.3864033e-06,-0.1591845,-1.048592
trans-Golgi Network Vesicle Budding,9.337112e-05,2.0,9.337112e-05,-0.10972455,0.15487176
Erythrocytes take up oxygen and release carbon dioxide,3.7619765e-07,2.0,3.7619765e-07,-0.16083907,0.11864577
Reversal of alkylation damage by DNA dioxygenases,2.1210305e-07,3.0,2.1210305e-07,-0.16092925,-0.04833391
Smooth Muscle Contraction,7.791406e-07,2.0,7.791406e-07,-0.16061758,0.11880274
Signaling by ERBB2,2.7615854e-06,9.0,2.7615854e-06,-0.15952794,-1.0488354
Branched-chain amino acid catabolism,0.0,2.0,0.0,-0.16104583,0.11849923
Synthesis of IPs in the nucleus,4.329665e-08,2.0,4.329665e-08,-0.16102204,0.1185161
Diseases associated with surfactant metabolism,2.5024583e-08,8.0,2.5024583e-08,-0.16103208,-0.88298565
Erythrocytes take up carbon dioxide and release oxygen,5.2823744e-08,2.0,5.2823744e-08,-0.1610168,0.118519805
Growth hormone receptor signaling,2.2663697e-05,2.0,2.2663697e-05,-0.14858876,0.12732783
PIWI-interacting RNA (piRNA) biogenesis,6.203492e-05,2.0,6.203492e-05,-0.12694845,0.14266482
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.00015917789,3.0,0.00015917789,-0.073553964,0.013590917
Complement cascade,0.0007396384,5.0,0.0007396384,0.24549522,-0.09412328
Integrin cell surface interactions,0.0005192339,2.0,0.0005192339,0.12435022,0.32076582
Signaling by Activin,2.1445128e-08,2.0,2.1445128e-08,-0.16103405,0.11850759
tRNA modification in the mitochondrion,3.4114353e-07,2.0,3.4114353e-07,-0.16085832,0.11863212
DNA Double Strand Break Response,0.00025380668,3.0,0.00025380668,-0.021541405,0.05045339
DAP12 interactions,5.2773944e-06,2.0,5.2773944e-06,-0.15814511,0.12055503
Threonine catabolism,8.7471926e-05,2.0,8.7471926e-05,-0.11296703,0.15257376
mRNA Editing: C to U Conversion,2.2472608e-07,2.0,2.2472608e-07,-0.1609223,0.11858677
Nucleosome assembly,7.743881e-08,2.0,7.743881e-08,-0.16100326,0.118529394
Ca2+ activated K+ channels,1.3111324e-07,2.0,1.3111324e-07,-0.16097377,0.11855031
Cell-cell junction organization,4.004327e-07,4.0,4.004327e-07,-0.16082573,-0.21517631
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),9.7905264e-08,2.0,9.7905264e-08,-0.16099203,0.11853737
SLC transporter disorders,5.595448e-07,73.0,7.6649975e-09,-0.16104163,-11.732302
Transcriptional regulation of white adipocyte differentiation,3.476853e-07,2.0,3.476853e-07,-0.16085474,0.11863466
Fructose metabolism,0.0002895645,3.0,0.0002895645,-0.0018871832,0.06438278
Pentose phosphate pathway,1.6035744e-06,2.0,1.6035744e-06,-0.16016445,0.11912389
Interconversion of nucleotide di- and triphosphates,3.3837525e-06,2.0,3.3837525e-06,-0.15918596,0.11981737
Acrosome Reaction,0.0,2.0,0.0,-0.16104583,0.11849923
PI3K/AKT Signaling in Cancer,4.0339842e-07,4.0,4.0339842e-07,-0.1608241,-0.21517515
tRNA processing in the mitochondrion,4.3503157e-10,2.0,4.3503157e-10,-0.1610456,0.118499406
DNA replication initiation,1.85315e-05,2.0,1.85315e-05,-0.15086001,0.12571813
Signaling by Insulin receptor,1.2176075e-06,3.0,1.2176075e-06,-0.16037658,-0.04794221
"Transport of bile salts and organic acids, metal ions and amine compounds",0.00015407588,8.0,0.00015407588,-0.07635827,-0.8229754
Phase 1 - inactivation of fast Na+ channels,4.2299243e-07,2.0,4.2299243e-07,-0.16081333,0.118664004
RAB geranylgeranylation,0.00011213464,2.0,0.00011213464,-0.09941121,0.16218108
Translocation of SLC2A4 (GLUT4) to the plasma membrane,0.00027399126,2.0,0.00027399126,-0.010446982,0.225232
Diseases associated with O-glycosylation of proteins,6.247971e-10,10.0,6.247971e-10,-0.16104549,-1.2168267
ATF6 (ATF6-alpha) activates chaperones,3.4770987e-05,2.0,3.4770987e-05,-0.14193402,0.1320442
PP2A-mediated dephosphorylation of key metabolic factors,6.203041e-07,2.0,6.203041e-07,-0.1607049,0.118740864
snRNP Assembly,4.3321444e-10,2.0,4.3321444e-10,-0.1610456,0.118499406
O-linked glycosylation,0.00015637491,3.0,0.00015637491,-0.07509462,0.012499021
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,2.389434e-07,2.0,2.389434e-07,-0.1609145,0.11859231
Interaction With The Zona Pellucida,4.3672736e-07,2.0,4.3672736e-07,-0.16080579,0.11866936
Phase 2 - plateau phase,4.4593797e-08,2.0,4.4593797e-08,-0.16102132,0.118516594
mRNA decay by 5' to 3' exoribonuclease,4.024693e-06,2.0,4.024693e-06,-0.15883367,0.12006704
GPCR downstream signalling,2.2146955e-05,7.0,2.2146955e-05,-0.1488728,-0.70745224
Signaling by BMP,7.6464995e-10,2.0,7.6464995e-10,-0.16104542,0.11849952
Signaling by FGFR,2.3327273e-06,5.0,2.3327273e-06,-0.15976365,-0.38133934
Meiotic recombination,0.0011261236,2.0,0.0011261236,0.45792618,0.5571786
Degradation of beta-catenin by the destruction complex,4.0817213e-05,3.0,4.0817213e-05,-0.13861072,-0.032516263
MAPK1/MAPK3 signaling,5.5112587e-06,3.0,5.5112587e-06,-0.15801659,-0.046269633
Transcriptional regulation by small RNAs,0.0010467165,2.0,0.0010467165,0.41428018,0.52624565
Intestinal lipid absorption,0.0,2.0,0.0,-0.16104583,0.11849923
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),0.00010610939,2.0,0.00010610939,-0.10272298,0.15983394
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),1.3177622e-05,2.0,1.3177622e-05,-0.15380277,0.12363255
LGI-ADAM interactions,8.6012307e-07,2.0,8.6012307e-07,-0.16057307,0.118834294
Post-transcriptional silencing by small RNAs,2.6849276e-07,2.0,2.6849276e-07,-0.16089827,0.11860382
RORA activates gene expression,5.5072388e-08,2.0,5.5072388e-08,-0.16101557,0.118520685
Cell-extracellular matrix interactions,1.4962595e-05,3.0,1.4962595e-05,-0.15282166,-0.042587884
Prostacyclin signalling through prostacyclin receptor,8.5198116e-07,2.0,8.5198116e-07,-0.16057754,0.11883112
Regulation of gene expression in beta cells,2.0536827e-08,2.0,2.0536827e-08,-0.16103454,0.11850723
MTF1 activates gene expression,1.7925575e-07,2.0,1.7925575e-07,-0.16094731,0.11856905
Signaling by Leptin,1.8130035e-06,2.0,1.8130035e-06,-0.16004932,0.119205475
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1.7263173e-07,2.0,1.7263173e-07,-0.16095094,0.11856648
Aflatoxin activation and detoxification,4.124876e-06,2.0,4.124876e-06,-0.1587786,0.12010607
SUMOylation,1.670522e-05,3.0,1.670522e-05,-0.15186384,-0.041909046
Signaling by ROBO receptors,0.00052471115,9.0,0.00052471115,0.1273608,-0.8455109
Receptor Mediated Mitophagy,1.6558588e-05,2.0,1.6558588e-05,-0.15194443,0.1249496
Formation of the cornified envelope,0.0008010236,2.0,0.0008010236,0.2792355,0.4305365
Metabolism of steroids,2.4930836e-05,6.0,2.4930836e-05,-0.14734264,-0.539452
Pre-NOTCH Expression and Processing,4.1403264e-06,4.0,4.1403264e-06,-0.1587701,-0.21371946
Phase 0 - rapid depolarisation,2.6621105e-08,2.0,2.6621105e-08,-0.1610312,0.118509606
Hedgehog ligand biogenesis,2.4334465e-08,2.0,2.4334465e-08,-0.16103247,0.118508704
Signaling by VEGF,6.2569194e-07,4.0,6.2569194e-07,-0.16070192,-0.21508856
IPs transport between nucleus and cytosol,0.0,2.0,0.0,-0.16104583,0.11849923
Intraflagellar transport,4.537488e-05,2.0,4.537488e-05,-0.13610561,0.13617493
"TET1,2,3 and TDG demethylate DNA",1.8182522e-08,2.0,1.8182522e-08,-0.16103584,0.11850631
WNT ligand biogenesis and trafficking,9.155285e-08,2.0,9.155285e-08,-0.16099551,0.1185349
Collagen biosynthesis and modifying enzymes,4.141203e-05,2.0,4.141203e-05,-0.13828379,0.13463122
Mitochondrial transcription initiation,3.3633736e-05,2.0,3.3633736e-05,-0.14255911,0.13160118
"Synthesis, secretion, and deacylation of Ghrelin",7.417774e-06,2.0,7.417774e-06,-0.15696867,0.121388815
ABC transporters in lipid homeostasis,0.00022685138,2.0,0.00022685138,-0.036357343,0.20686875
Regulation of gene expression in early pancreatic precursor cells,0.0,2.0,0.0,-0.16104583,0.11849923
RMTs methylate histone arginines,3.260734e-05,2.0,3.260734e-05,-0.14312325,0.13120136
HCN channels,2.3114441e-07,2.0,2.3114441e-07,-0.16091879,0.11858927
Post-translational protein phosphorylation,1.7168832e-05,2.0,1.7168832e-05,-0.151609,0.12518732
Signaling by WNT in cancer,2.435679e-06,11.0,2.435679e-06,-0.15970707,-1.3827938
Defective Mismatch Repair Associated With MSH6,2.6194526e-12,2.0,2.6194526e-12,-0.16104583,0.11849923
Neurotransmitter receptors and postsynaptic signal transmission,8.4071915e-05,6.0,8.4071915e-05,-0.11483584,-0.51641375
Prolactin receptor signaling,4.2658075e-06,2.0,4.2658075e-06,-0.15870114,0.12016096
Electron transport from NADPH to Ferredoxin,6.050438e-07,2.0,6.050438e-07,-0.16071327,0.11873492
Signaling by NOTCH1 in Cancer,6.728444e-07,6.0,6.728444e-07,-0.160676,-0.5489017
Heme biosynthesis,7.655686e-06,2.0,7.655686e-06,-0.15683791,0.121481486
Defective Mismatch Repair Associated With MSH3,3.0440797e-10,2.0,3.0440797e-10,-0.16104567,0.11849934
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,0.0,2.0,0.0,-0.16104583,0.11849923
Electric Transmission Across Gap Junctions,4.4312915e-06,2.0,4.4312915e-06,-0.15861018,0.12022543
RNA Polymerase II Transcription Initiation And Promoter Clearance,4.839054e-05,3.0,4.839054e-05,-0.13444805,-0.029566096
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",1.6009644e-05,2.0,1.6009644e-05,-0.15224616,0.12473576
Defective Mismatch Repair Associated With MSH2,1.8098809e-10,2.0,1.8098809e-10,-0.16104575,0.118499294
L1CAM interactions,2.3262386e-07,7.0,2.3262386e-07,-0.16091797,-0.71598893
MAPK6/MAPK4 signaling,3.0442245e-06,2.0,3.0442245e-06,-0.15937258,0.119685106
Interferon Signaling,0.0019724017,4.0,0.0019724017,0.9230816,0.55301315
Syndecan interactions,0.000112549904,2.0,0.000112549904,-0.09918296,0.16234283
RNA Polymerase III Abortive And Retractive Initiation,5.902593e-07,2.0,5.902593e-07,-0.1607214,0.11872917
Cellular hexose transport,7.242169e-06,2.0,7.242169e-06,-0.15706518,0.1213204
Signaling by FGFR in disease,7.219993e-08,5.0,7.219993e-08,-0.16100615,-0.3822199
Synaptic adhesion-like molecules,2.0793921e-05,2.0,2.0793921e-05,-0.14961648,0.12659946
ECM proteoglycans,0.00018856121,2.0,0.00018856121,-0.057403468,0.1919529
ABC transporter disorders,2.069429e-07,16.0,2.069429e-07,-0.16093208,-2.2182407
Transport of glycerol from adipocytes to the liver by Aquaporins,0.0,2.0,0.0,-0.16104583,0.11849923
DDX58/IFIH1-mediated induction of interferon-alpha/beta,0.0034878177,6.0,0.0034878177,1.7560275,0.80950916
RNA Polymerase I Transcription Termination,0.0015637805,2.0,0.0015637805,0.6984836,0.727667
Chaperonin-mediated protein folding,4.1616913e-06,4.0,4.1616913e-06,-0.15875836,-0.21371113
mRNA Splicing,0.0028164838,3.0,0.0028164838,1.38703,1.0487396
Sulfur amino acid metabolism,7.431608e-06,4.0,7.431608e-06,-0.15696107,-0.21243733
Nitric oxide stimulates guanylate cyclase,8.1841165e-08,2.0,8.1841165e-08,-0.16100085,0.11853111
Signaling by PDGF,7.849271e-09,2.0,7.849271e-09,-0.16104151,0.11850229
Apoptotic execution phase,6.053916e-07,4.0,6.053916e-07,-0.16071308,-0.21509647
M Phase,0.000101970654,5.0,0.000101970654,-0.10499783,-0.34252557
Negative epigenetic regulation of rRNA expression,0.030552795,3.0,0.030552795,16.632248,11.853369
Extrinsic Pathway of Fibrin Clot Formation,2.0007304e-08,2.0,2.0007304e-08,-0.16103484,0.11850702
Transcriptional activation of mitochondrial biogenesis,7.5773987e-06,2.0,7.5773987e-06,-0.15688093,0.12145098
ER to Golgi Anterograde Transport,9.6818476e-05,4.0,9.6818476e-05,-0.10782971,-0.17761686
Uptake and actions of bacterial toxins,7.7703575e-08,5.0,7.7703575e-08,-0.16100313,-0.38221774
mTORC1-mediated signalling,5.029818e-07,2.0,5.029818e-07,-0.16076937,0.118695155
tRNA modification in the nucleus and cytosol,1.9521972e-10,2.0,1.9521972e-10,-0.16104572,0.11849931
Pyruvate metabolism and Citric Acid (TCA) cycle,5.8337096e-06,4.0,5.8337096e-06,-0.15783934,-0.21305978
Toll-Like Receptors Cascades,0.0005407184,10.0,0.0005407184,0.13615915,-1.006191
Deadenylation of mRNA,1.9254638e-05,2.0,1.9254638e-05,-0.15046255,0.12599984
Regulation of signaling by NODAL,3.802655e-05,2.0,3.802655e-05,-0.1401446,0.13331239
Signal amplification,1.09012085e-07,4.0,1.09012085e-07,-0.16098592,-0.21528985
HIV Infection,1.4458715e-07,3.0,1.4458715e-07,-0.16096637,-0.048360206
IP3 and IP4 transport between cytosol and nucleus,0.0,2.0,0.0,-0.16104583,0.11849923
Cristae formation,2.6749788e-07,2.0,2.6749788e-07,-0.1608988,0.11860342
p75 NTR receptor-mediated signalling,4.0420937e-06,8.0,4.0420937e-06,-0.15882412,-0.8814208
Signaling by MST1,0.0,2.0,0.0,-0.16104583,0.11849923
Netrin-1 signaling,9.50321e-06,5.0,9.50321e-06,-0.15582241,-0.37854606
Diseases associated with N-glycosylation of proteins,0.0,17.0,0.0,-0.16104583,-2.3852372
Sphingolipid metabolism,7.7579057e-07,3.0,7.7579057e-07,-0.16061942,-0.04811432
"Synthesis of IP2, IP, and Ins in the cytosol",3.7101572e-07,2.0,3.7101572e-07,-0.16084191,0.11864376
RNA Polymerase I Promoter Clearance,1.6180291e-05,4.0,1.6180291e-05,-0.15215236,-0.20902929
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,6.066792e-10,2.0,6.066792e-10,-0.16104549,0.118499465
Metabolism of water-soluble vitamins and cofactors,0.0010820475,11.0,0.0010820475,0.43369982,-0.962233
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,3.7789658e-07,2.0,3.7789658e-07,-0.16083813,0.11864643
Global Genome Nucleotide Excision Repair (GG-NER),2.920671e-05,5.0,2.920671e-05,-0.14499241,-0.37087062
Amyloid fiber formation,0.002114957,2.0,0.002114957,1.0014368,0.9423768
Vasopressin regulates renal water homeostasis via Aquaporins,0.00013856195,2.0,0.00013856195,-0.08488548,0.17247579
rRNA processing in the nucleus and cytosol,0.00016881035,3.0,0.00016881035,-0.0682595,0.017343229
Signal regulatory protein family interactions,3.5883193e-07,2.0,3.5883193e-07,-0.1608486,0.11863901
Mitochondrial transcription termination,9.85529e-06,2.0,9.85529e-06,-0.15562889,0.12233833
tRNA Aminoacylation,6.5221825e-06,3.0,6.5221825e-06,-0.15746093,-0.045875832
RNA Pol II CTD phosphorylation and interaction with CE,7.745712e-06,2.0,7.745712e-06,-0.15678841,0.121516556
HATs acetylate histones,3.7476133e-07,2.0,3.7476133e-07,-0.16083984,0.11864521
FasL/ CD95L signaling,1.6414615e-08,2.0,1.6414615e-08,-0.16103682,0.11850563
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,5.1065695e-06,2.0,5.1065695e-06,-0.15823902,0.12048847
Nucleobase biosynthesis,2.2194234e-08,3.0,2.2194234e-08,-0.16103363,-0.04840788
Diseases of carbohydrate metabolism,6.815436e-09,8.0,6.815436e-09,-0.1610421,-0.88299274
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",2.1201417e-05,4.0,2.1201417e-05,-0.14939252,-0.20707335
TCF dependent signaling in response to WNT,1.289859e-05,10.0,1.289859e-05,-0.15395615,-1.2118022
Passive transport by Aquaporins,3.0995386e-09,2.0,3.0995386e-09,-0.16104414,0.11850043
Metabolic disorders of biological oxidation enzymes,9.3691895e-11,33.0,2.8391484e-12,-0.16104583,-5.0558896
Anchoring of the basal body to the plasma membrane,3.455382e-06,2.0,3.455382e-06,-0.15914659,0.11984527
Neurexins and neuroligins,1.1103386e-05,2.0,1.1103386e-05,-0.15494289,0.12282453
Deubiquitination,1.5978481e-05,6.0,1.5978481e-05,-0.1522633,-0.5429394
DAG and IP3 signaling,2.7266117e-07,2.0,2.7266117e-07,-0.16089596,0.11860544
Processing of Intronless Pre-mRNAs,7.059909e-07,2.0,7.059909e-07,-0.16065778,0.11877425
Post-translational modification: synthesis of GPI-anchored proteins,6.2478444e-05,4.0,6.2478444e-05,-0.12670466,-0.19099395
Integrin alphaIIb beta3 signaling,7.70722e-06,3.0,7.70722e-06,-0.15680957,-0.045414202
AUF1 (hnRNP D0) binds and destabilizes mRNA,0.00036881087,2.0,0.00036881087,0.041670464,0.26216882
Synthesis of IPs in the ER lumen,0.0,2.0,0.0,-0.16104583,0.11849923
Intracellular oxygen transport,0.0,2.0,0.0,-0.16104583,0.11849923
Peptide hormone biosynthesis,0.0,2.0,0.0,-0.16104583,0.11849923
Amino acid synthesis and interconversion (transamination),2.4658948e-05,2.0,2.4658948e-05,-0.14749208,0.12810507
TYSND1 cleaves peroxisomal proteins,2.7390231e-05,2.0,2.7390231e-05,-0.14599085,0.12916903
Synthesis of pyrophosphates in the cytosol,7.9786755e-10,2.0,7.9786755e-10,-0.1610454,0.11849953
Homology Directed Repair,0.004174801,3.0,0.004174801,2.133627,1.5778695
Scavenging by Class F Receptors,3.9518625e-05,2.0,3.9518625e-05,-0.13932449,0.13389364
Signaling by NOTCH1,3.046698e-08,3.0,3.046698e-08,-0.16102909,-0.048404668
Nonhomologous End-Joining (NHEJ),0.0030679863,2.0,0.0030679863,1.5252678,1.3136276
Neutrophil degranulation,0.0005990954,2.0,0.0005990954,0.168246,0.35187575
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",2.5981294e-08,2.0,2.5981294e-08,-0.16103154,0.11850935
Abacavir transmembrane transport,0.0,2.0,0.0,-0.16104583,0.11849923
mRNA decay by 3' to 5' exoribonuclease,0.00013728112,2.0,0.00013728112,-0.08558948,0.17197683
Scavenging of heme from plasma,1.1796873e-05,2.0,1.1796873e-05,-0.15456171,0.12309468
Pyrophosphate hydrolysis,0.0,2.0,0.0,-0.16104583,0.11849923
Collagen degradation,7.5416875e-07,2.0,7.5416875e-07,-0.16063131,0.11879301
Signaling by EGFR in Cancer,2.787689e-06,4.0,2.787689e-06,-0.1595136,-0.21424635
Costimulation by the CD28 family,0.0007120375,4.0,0.0007120375,0.23032442,0.062040593
Post-chaperonin tubulin folding pathway,2.0692129e-08,2.0,2.0692129e-08,-0.16103446,0.11850729
Selenoamino acid metabolism,0.00021293612,8.0,0.00021293612,-0.044005837,-0.80004656
Cytosolic sensors of pathogen-associated DNA ,0.00052391033,6.0,0.00052391033,0.12692063,-0.34507552
Signaling by EGFR,6.870483e-09,6.0,6.870483e-09,-0.16104206,-0.5491611
Galactose catabolism,2.1415071e-05,2.0,2.1415071e-05,-0.14927508,0.12684143
Insulin processing,1.3939967e-05,2.0,1.3939967e-05,-0.15338375,0.123929515
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,1.1356701e-05,2.0,1.1356701e-05,-0.15480365,0.12292321
Hedgehog 'off' state,4.114148e-07,4.0,4.114148e-07,-0.16081971,-0.21517202
Phospholipid metabolism,1.7877346e-06,3.0,1.7877346e-06,-0.1600632,-0.047720127
Insulin effects increased synthesis of Xylulose-5-Phosphate,2.7458247e-05,2.0,2.7458247e-05,-0.14595346,0.12919554
Transferrin endocytosis and recycling,2.2028322e-05,2.0,2.2028322e-05,-0.14893802,0.12708032
TNF signaling,1.7651729e-06,5.0,1.7651729e-06,-0.1600756,-0.38156044
Voltage gated Potassium channels,3.6014e-07,2.0,3.6014e-07,-0.16084789,0.118639514
Carboxyterminal post-translational modifications of tubulin,2.870636e-08,2.0,2.870636e-08,-0.16103007,0.11851041
Sperm:Oocyte Membrane Binding,2.2408095e-07,2.0,2.2408095e-07,-0.16092268,0.11858652
Signaling by NOTCH2,3.075398e-08,3.0,3.075398e-08,-0.16102892,-0.048404552
GPCR ligand binding,2.8367086e-07,4.0,2.8367086e-07,-0.16088991,-0.21522179
Platelet sensitization by LDL,1.1317552e-06,2.0,1.1317552e-06,-0.16042377,0.11894011
RNA Polymerase II Pre-transcription Events,6.813762e-05,2.0,6.813762e-05,-0.1235941,0.1450421
Signaling by TGF-beta Receptor Complex in Cancer,1.09391756e-07,5.0,1.09391756e-07,-0.16098571,-0.38220543
Response to elevated platelet cytosolic Ca2+,6.282467e-05,3.0,6.282467e-05,-0.12651436,-0.023943301
Meiotic synapsis,0.0002998948,2.0,0.0002998948,0.0037908591,0.23532268
Physiological factors,4.731103e-10,2.0,4.731103e-10,-0.16104558,0.11849941
Semaphorin interactions,0.00033826474,6.0,0.00033826474,0.024880832,-0.41739336
Scavenging by Class B Receptors,6.362444e-07,2.0,6.362444e-07,-0.16069613,0.11874708
Intrinsic Pathway for Apoptosis,7.5148932e-06,8.0,7.5148932e-06,-0.15691528,-0.880068
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,4.95461e-06,2.0,4.95461e-06,-0.15832254,0.120429285
Assembly of collagen fibrils and other multimeric structures,0.0,3.0,0.0,-0.16104583,-0.048416536
Ion homeostasis,0.00011783991,2.0,0.00011783991,-0.096275315,0.16440354
Effects of PIP2 hydrolysis,6.139078e-09,2.0,6.139078e-09,-0.16104245,0.11850162
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,5.7804802e-05,2.0,5.7804802e-05,-0.12927352,0.14101699
Caspase activation via extrinsic apoptotic signalling pathway,6.161107e-05,3.0,6.161107e-05,-0.12718141,-0.024416054
Detoxification of Reactive Oxygen Species,2.4279223e-07,2.0,2.4279223e-07,-0.1609124,0.118593805
Ketone body metabolism,1.7828924e-08,3.0,1.7828924e-08,-0.16103603,-0.048409577
Neddylation,0.0003375537,2.0,0.0003375537,0.024490014,0.24999262
mRNA Editing: A to I Conversion,3.2119578e-07,3.0,3.2119578e-07,-0.1608693,-0.04829141
Neurotransmitter release cycle,8.181044e-05,7.0,8.181044e-05,-0.11607886,-0.6842104
ChREBP activates metabolic gene expression,3.216441e-08,2.0,3.216441e-08,-0.16102816,0.11851176
Generic Transcription Pathway,0.0036579024,11.0,0.0036579024,1.8495142,0.041186463
RIPK1-mediated regulated necrosis,6.5410627e-06,2.0,6.5410627e-06,-0.15745056,0.12104729
Defective Mismatch Repair Associated With MLH1,5.830607e-12,2.0,5.830607e-12,-0.16104583,0.11849923
Fibronectin matrix formation,0.0,2.0,0.0,-0.16104583,0.11849923
Platelet Aggregation (Plug Formation),2.0129495e-11,2.0,2.0129495e-11,-0.16104582,0.11849924
Fc epsilon receptor (FCERI) signaling,0.0015343691,5.0,0.0015343691,0.6823177,0.21546255
Antimicrobial peptides,1.5952238e-06,4.0,1.5952238e-06,-0.16016904,-0.2147109
Mitotic Spindle Checkpoint,1.256638e-05,3.0,1.256638e-05,-0.15413874,-0.04352132
PECAM1 interactions,7.1604575e-07,2.0,7.1604575e-07,-0.16065226,0.11877817
Resolution of Abasic Sites (AP sites),1.3762048e-05,5.0,1.3762048e-05,-0.15348156,-0.37688708
Neurotransmitter uptake and metabolism In glial cells,1.0429678e-08,2.0,1.0429678e-08,-0.16104011,0.11850329
Signaling by Interleukins,0.00029626783,12.0,0.00029626783,0.0017972967,-1.4352477
Intestinal hexose absorption,0.0,2.0,0.0,-0.16104583,0.11849923
Signaling by NOTCH3,6.172839e-07,3.0,6.172839e-07,-0.16070653,-0.04817607
Tie2 Signaling,1.6514993e-07,2.0,1.6514993e-07,-0.16095506,0.11856357
Reelin signalling pathway,3.052975e-07,2.0,3.052975e-07,-0.16087803,0.11861816
Type I hemidesmosome assembly,1.74352e-06,2.0,1.74352e-06,-0.16008751,0.11917842
DNA Replication Pre-Initiation,0.0005923315,3.0,0.0005923315,0.16452822,0.18232511
Beta-catenin independent WNT signaling,0.00010819555,3.0,0.00010819555,-0.10157632,-0.006269153
Cellular response to hypoxia,0.00029268392,2.0,0.00029268392,-0.00017259027,0.23251371
"Gamma carboxylation, hypusine formation and arylsulfatase activation",1.1478979e-05,5.0,1.1478979e-05,-0.15473643,-0.37777644
HDMs demethylate histones,9.322902e-09,2.0,9.322902e-09,-0.16104071,0.118502855
Synthesis of IP3 and IP4 in the cytosol,7.1483555e-06,2.0,7.1483555e-06,-0.15711674,0.12128386
Activation of anterior HOX genes in hindbrain development during early embryogenesis,8.897806e-05,2.0,8.897806e-05,-0.11213919,0.15316047
Cellular Senescence,0.00080310355,5.0,0.00080310355,0.28037873,-0.06940056
PRC2 methylates histones and DNA,0.00048649783,2.0,0.00048649783,0.10635691,0.30801356
Digestion of dietary lipid,0.0,2.0,0.0,-0.16104583,0.11849923
RNA Polymerase III Chain Elongation,7.592445e-07,2.0,7.592445e-07,-0.16062853,0.11879499
TNFR2 non-canonical NF-kB pathway,1.9901142e-06,4.0,1.9901142e-06,-0.15995197,-0.21455705
Defects in vitamin and cofactor metabolism,4.382786e-07,3.0,4.382786e-07,-0.16080494,-0.0482458
Phase II - Conjugation of compounds,0.00037737223,7.0,0.00037737223,0.0463762,-0.56907487
DNA methylation,0.007735946,2.0,0.007735946,4.0910044,3.1320226
RNA Polymerase III Transcription Termination,1.0061647e-06,2.0,1.0061647e-06,-0.1604928,0.11889119
Metabolism of cofactors,1.6712705e-05,4.0,1.6712705e-05,-0.15185973,-0.20882191
Reversible hydration of carbon dioxide,6.3734305e-08,2.0,6.3734305e-08,-0.1610108,0.11852405
Metabolism of Angiotensinogen to Angiotensins,3.1208829e-06,2.0,3.1208829e-06,-0.15933044,0.11971497
Regulation of mitotic cell cycle,1.7918935e-06,2.0,1.7918935e-06,-0.16006093,0.11919726
Scavenging by Class A Receptors,1.3774526e-06,2.0,1.3774526e-06,-0.16028872,0.11903582
Receptor-type tyrosine-protein phosphatases,1.0954452e-05,2.0,1.0954452e-05,-0.15502474,0.12276651
Signaling by ERBB4,2.0407371e-07,5.0,2.0407371e-07,-0.16093366,-0.38216853
NR1D1 (REV-ERBA) represses gene expression,1.5159343e-10,2.0,1.5159343e-10,-0.16104576,0.11849929
Phase 3 - rapid repolarisation,8.9705104e-08,2.0,8.9705104e-08,-0.16099653,0.11853417
AMPK inhibits chREBP transcriptional activation activity,8.062892e-08,2.0,8.062892e-08,-0.16100152,0.11853063
PKMTs methylate histone lysines,1.6894455e-05,2.0,1.6894455e-05,-0.15175982,0.12508044
Scavenging by Class H Receptors,6.656977e-12,2.0,6.656977e-12,-0.16104583,0.11849923
TCR signaling,2.0139953e-05,5.0,2.0139953e-05,-0.14997594,-0.37440255
Pink/Parkin Mediated Mitophagy,7.282595e-06,2.0,7.282595e-06,-0.15704297,0.12133615
PIP3 activates AKT signaling,4.6144643e-05,5.0,4.6144643e-05,-0.13568251,-0.36427248
MHC class II antigen presentation,0.006040876,2.0,0.006040876,3.1593118,2.4717114
PERK regulates gene expression,8.304705e-07,2.0,8.304705e-07,-0.16058937,0.118822746
Melanin biosynthesis,0.0,2.0,0.0,-0.16104583,0.11849923
S Phase,1.113577e-05,4.0,1.113577e-05,-0.15492508,-0.2109944
Hedgehog 'on' state,1.284612e-05,4.0,1.284612e-05,-0.153985,-0.21032813
Invadopodia formation,6.01015e-06,2.0,6.01015e-06,-0.15774237,0.12084047
Class I MHC mediated antigen processing & presentation,0.011543144,4.0,0.011543144,6.1836243,4.281278
Metallothioneins bind metals,0.0,2.0,0.0,-0.16104583,0.11849923
Lactose synthesis,1.662341e-05,2.0,1.662341e-05,-0.1519088,0.12497485
Recognition of DNA damage by PCNA-containing replication complex,0.00025469472,2.0,0.00025469472,-0.021053294,0.21771508
Basigin interactions,0.0010560768,2.0,0.0010560768,0.4194251,0.529892
Eukaryotic Translation Termination,1.2395017e-06,2.0,1.2395017e-06,-0.16036454,0.11898208
Fcgamma receptor (FCGR) dependent phagocytosis,0.00040578315,4.0,0.00040578315,0.06199222,-0.05726021
Glyoxylate metabolism and glycine degradation,7.6329417e-07,2.0,7.6329417e-07,-0.16062628,0.11879657
Nucleobase catabolism,3.7710154e-06,4.0,3.7710154e-06,-0.1589731,-0.21386331
CDO in myogenesis,4.5129514e-06,2.0,4.5129514e-06,-0.1585653,0.12025724
MicroRNA (miRNA) biogenesis,7.496178e-05,2.0,7.496178e-05,-0.119843215,0.14770044
Oncogenic MAPK signaling,3.0444808e-06,7.0,3.0444808e-06,-0.15937243,-0.7148936
Stimuli-sensing channels,8.2878076e-05,2.0,8.2878076e-05,-0.11549203,0.15078424
Nephrin family interactions,3.853502e-06,2.0,3.853502e-06,-0.15892777,0.12000035
Eukaryotic Translation Elongation,8.271548e-06,2.0,8.271548e-06,-0.1564994,0.121721394
Signaling by Retinoic Acid,1.2340906e-09,2.0,1.2340906e-09,-0.16104516,0.11849971
Presynaptic depolarization and calcium channel opening,4.7944795e-06,2.0,4.7944795e-06,-0.15841056,0.12036691
Telomere Maintenance,7.1609355e-07,3.0,7.1609355e-07,-0.16065224,-0.048137575
Metabolism of fat-soluble vitamins,1.1705604e-08,4.0,1.1705604e-08,-0.1610394,-0.21532774
TRAIL  signaling,7.106882e-08,2.0,7.106882e-08,-0.16100676,0.11852691
Rho GTPase cycle,4.5306692e-07,2.0,4.5306692e-07,-0.1607968,0.118675716
mRNA Capping,4.6318013e-07,2.0,4.6318013e-07,-0.16079125,0.118679665
Biosynthesis of specialized proresolving mediators (SPMs),3.330505e-06,6.0,3.330505e-06,-0.15921523,-0.5478664
Fanconi Anemia Pathway,0.0024114042,2.0,0.0024114042,1.1643786,1.0578573
Thrombin signalling through proteinase activated receptors (PARs),3.192459e-06,2.0,3.192459e-06,-0.1592911,0.11974284
IPs transport between nucleus and ER lumen,0.0,2.0,0.0,-0.16104583,0.11849923
Defective Mismatch Repair Associated With PMS2,7.0999616e-11,2.0,7.0999616e-11,-0.1610458,0.11849926
PKA-mediated phosphorylation of key metabolic factors,7.355343e-07,2.0,7.355343e-07,-0.16064155,0.11878576
eNOS activation and regulation,2.4589372e-07,4.0,2.4589372e-07,-0.16091068,-0.21523651
Phase 4 - resting membrane potential,5.992852e-08,2.0,5.992852e-08,-0.1610129,0.11852258
Endosomal Sorting Complex Required For Transport (ESCRT),3.150001e-05,2.0,3.150001e-05,-0.1437319,0.13077
Regulation of insulin secretion,2.3995096e-06,5.0,2.3995096e-06,-0.15972695,-0.38131332
Signaling by NTRKs,1.5449858e-06,5.0,1.5449858e-06,-0.16019665,-0.3816462
G1/S DNA Damage Checkpoints,2.1401074e-05,3.0,2.1401074e-05,-0.14928277,-0.04007979
Sperm Motility And Taxes,2.8219822e-07,2.0,2.8219822e-07,-0.16089073,0.11860915
